TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19602953

Group type: EXPERIMENTAL
Intervention: General anesthesia (combination of one of four hypnotic drugs supplemented by one of four opioids)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 156
Study: 17610727

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate (SAL/FP) 50/250 mug BID
Number of subjects: 688

Group type: COMPARATOR
Intervention: Formoterol/budesonide (FOR/BUD) 6/200 mug BID
Number of subjects: 688
Study: 15269071

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 800

Group type: COMPARATOR
Intervention: No influenza vaccine (Control)
Number of subjects: 800
Study: 12477513

Group type: EXPERIMENTAL
Intervention: Carnitines (group A; n = 30) for 4 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory drugs (group B; n = 16) for 4 months
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs for 2 months, followed by carnitines for 2 months (group C; n = 26)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory treatment given concomitantly with carnitines (group D; n = 26) for 4 months
Number of subjects: 98
Study: 9822455

Group type: EXPERIMENTAL
Intervention: 1.25 mg of the ACE inhibitor enalaprilat
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7663641

Group type: EXPERIMENTAL
Intervention: Sway speed with eyes open (natural logarithm)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Sway speed with eyes closed (natural logarithm)
Number of subjects: 265
Study: 2696937

Group type: EXPERIMENTAL
Intervention: proxibarbal (Ipronal "Polfa") 50 mg tablets, administered one tablet twice daily for 6 weeks every quarter over 3 years
Number of subjects: 62

Group type: COMPARATOR
Intervention: placebo tablets, administered one tablet twice daily for 6 weeks every quarter over 3 years
Number of subjects: 62
Study: 798626

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg bid
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Tamoxifen 15 mg/m2 bid
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Tamoxifen (both dosages)
Number of subjects: 74
Study: 31565750

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (IIV3)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study: 29114517

Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation-based abdominal muscle strengthening training (PNF-AMST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional physical therapy (control)
Number of subjects: 30
Study: 24778425

Group type: EXPERIMENTAL
Intervention: Clot strength
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Platelet aggregation
Number of subjects: 40
Study: 23550791

Group type: EXPERIMENTAL
Intervention: GuardianCPV
Number of subjects: 120

Group type: COMPARATOR
Intervention: LMA Supreme
Number of subjects: 120
Study: 23804793

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 31)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (n = 24)
Number of subjects: 55
Study: 18990678

Group type: EXPERIMENTAL
Intervention: Budesonide (low-dose inhaled corticosteroid)
Number of subjects: 7165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7165

Group type: EXPERIMENTAL
Intervention: Budesonide vs Placebo
Number of subjects: 7165

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 7165
Study: 16942947

Group type: EXPERIMENTAL
Intervention: Conventional Pain Coping Skills Training (PCST)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Pain Coping Skills Training with Maintenance Training (PCST/MT)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Arthritis Education Control
Number of subjects: 167

Group type: COMPARATOR
Intervention: Standard Care Control
Number of subjects: 167
Study: 14986244

Group type: EXPERIMENTAL
Intervention: Intravenous and oral clinafloxacin treatment for native valve infection
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intravenous and oral clinafloxacin treatment for prosthetic valve endocarditis (PVE)
Number of subjects: 66
Study: 11380230

Group type: EXPERIMENTAL
Intervention: Combined chemotherapy and radiotherapy (CRT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combined chemotherapy and radiotherapy (CRT) after radical resection
Number of subjects: 70

Group type: COMPARATOR
Intervention: Radiotherapy (RT) after radical resection
Number of subjects: 70
Study: 9222074

Group type: EXPERIMENTAL
Intervention: Alatrofloxacin 30 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Alatrofloxacin 100 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Alatrofloxacin 200 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Alatrofloxacin 300 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Alatrofloxacin (all doses)
Number of subjects: 15
Study: 8107184

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (60 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 18
Study: 3663551

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (150 mg) alone
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate in combination with human menopausal gonadotrophins (hMG)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: hMG alone
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Clomiphene in combination with hMG
Number of subjects: 68
Study: 31259600

Group type: EXPERIMENTAL
Intervention: Holistic processing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relational representations
Number of subjects: 0
Study: 28467262

Group type: EXPERIMENTAL
Intervention: Group A: 3 × 12 minutes for two sessions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group B: 1 × 36 minutes over two sessions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 30
Study: 26695486

Group type: EXPERIMENTAL
Intervention: 1000 mg testosterone undecanoate (Nebido(®))
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 30 mg testosterone propionate, 60 mg testosterone phenylpropionate, 60 mg testosterone isocaproate, and 100 mg testosterone decanoate (Sustanon(®))
Number of subjects: 6

Group type: COMPARATOR
Intervention: Blood collection devices (stabilizing additives vs non‐stabilized serum separation tubes)
Number of subjects: 6
Study: 23968788

Group type: EXPERIMENTAL
Intervention: 10-week Tier 1 Response to Intervention (RtI) program
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 113
Study: 21674594

Group type: EXPERIMENTAL
Intervention: Experimental OAB drug
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 18269429

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (5-week programme and 3-month conversation group)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 308
Study: 16646405

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 337

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 337
Study: 15066366

Group type: EXPERIMENTAL
Intervention: Lifestyle Education for Activity Program (LEAP) - a comprehensive school-based intervention emphasizing changes in instruction and school environment.
Number of subjects: 2087

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 2087

Group type: EXPERIMENTAL
Intervention: Lifestyle Education for Activity Program (LEAP).
Number of subjects: 2087
Study: 11069725

Group type: EXPERIMENTAL
Intervention: Full irrigation with 3000 ml of saline
Number of subjects: 90

Group type: COMPARATOR
Intervention: Minimal irrigation with 250 ml saline
Number of subjects: 90
Study: 9312318

Group type: EXPERIMENTAL
Intervention: Dorzolamide
Number of subjects: 2

Group type: COMPARATOR
Intervention: Sodium chloride solution 0.9%
Number of subjects: 2

Group type: COMPARATOR
Intervention: Oxybuprocaine 0.4%
Number of subjects: 2
Study: 8467542

Group type: EXPERIMENTAL
Intervention: Group A: 2 ml bolus/10 min lockout interval
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Group B: 3 ml bolus/15 min lockout interval
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Group C: 4 ml bolus/20 min lockout interval
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Group D: 6 ml bolus/30 min lockout interval
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Group E: 8 ml/hr continuous infusion
Number of subjects: 68
Study: 3468737

Group type: EXPERIMENTAL
Intervention: EMG biofeedback treatment (8 sessions, twice a week for 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no EMG biofeedback)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (EXP and CON)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Objective clinical indices
Number of subjects: 0
Study: 30389092

Group type: EXPERIMENTAL
Intervention: Integrated PFI (computer-based personalized feedback intervention)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control PFI
Number of subjects: 68
Study: 30390654

Group type: EXPERIMENTAL
Intervention: Use of prophylaxis
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Duration of stay in a highly endemic region
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Frequency of travel
Number of subjects: 260

Group type: COMPARATOR
Intervention: Imported cases classification
Number of subjects: 260
Study: 26815248

Group type: EXPERIMENTAL
Intervention: C‐PEN
Number of subjects: 80

Group type: COMPARATOR
Intervention: C‐ESI
Number of subjects: 80
Study: 25491033

Group type: EXPERIMENTAL
Intervention: High-flux polysulfone membrane (Helixone®)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low-flux polysulfone membrane
Number of subjects: 90
Study: 21896558

Group type: EXPERIMENTAL
Intervention: Goal facilitation tool
Number of subjects: 205

Group type: COMPARATOR
Intervention: Standard needs assessment (Control)
Number of subjects: 205
Study: 21151493

Group type: EXPERIMENTAL
Intervention: RS4
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RS2
Number of subjects: 10

Group type: COMPARATOR
Intervention: Native starch (control)
Number of subjects: 10
Study: 17604178

Group type: EXPERIMENTAL
Intervention: Celsior
Number of subjects: 60

Group type: COMPARATOR
Intervention: St. Thomas No. 2
Number of subjects: 60
Study: 16085678

Group type: EXPERIMENTAL
Intervention: Diabetic patients (n=7)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control patients (n=5)
Number of subjects: 12
Study: 11866264

Group type: EXPERIMENTAL
Intervention: Anti-H. pylori therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chlorambucil p.o. for 6 months
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chlorambucil p.o. for 1 year
Number of subjects: 48

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 48
Study: 10752774

Group type: EXPERIMENTAL
Intervention: Short-term glucose infusion of 25 g in 30 min
Number of subjects: 26

Group type: COMPARATOR
Intervention: Continuous glucose infusion of 10 g/h
Number of subjects: 26
Study: 8638536

Group type: EXPERIMENTAL
Intervention: Neoadjuvant intraarterial infusion chemotherapy with 25 mg/m2 of cisplatin and 15 mg/m2 of bleomycin via each internal iliac artery.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group receiving radiation therapy (external irradiation and intracavitary irradiation).
Number of subjects: 50
Study: 1309493

Group type: COMPARATOR
Intervention: Intra-abdominal sepsis (Group 2)
Number of subjects: 17
Study: 6533162

Group type: EXPERIMENTAL
Intervention: Intracarotid urokinase injections
Number of subjects: 2
Study: 31169130

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age strata
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BMI and Age
Number of subjects: 0
Study: 28806208

Group type: EXPERIMENTAL
Intervention: iopromide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: iodixanol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline solution (NSS)
Number of subjects: 40
Study: 27312912

Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 20
Study: 25252032

Group type: EXPERIMENTAL
Intervention: 150kg/person of rice from non-KBD areas
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 7kg/family of selenium-iodine salt
Number of subjects: 280

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 280
Study: 22659373

Group type: EXPERIMENTAL
Intervention: Simvastatin alone (40 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin combined therapy (10/20 or 10/40 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All treated patients (including both interventions)
Number of subjects: 30
Study: 20481650

Group type: EXPERIMENTAL
Intervention: Vicriviroc 75 mg alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vicriviroc 15 mg after 4 days of ritonavir 100 mg once daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ritonavir treatment
Number of subjects: 12
Study: 18588757

Group type: EXPERIMENTAL
Intervention: Nasal irrigation (daily until 6 months after RT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Nonirrigation (no nasal irrigation after RT)
Number of subjects: 107
Study: 15911819

Group type: EXPERIMENTAL
Intervention: slow-frequency repetitive transcranial magnetic stimulation (rTMS) to the unaffected hemisphere
Number of subjects: 0

Group type: COMPARATOR
Intervention: sham rTMS
Number of subjects: 0
Study: 12431355

Group type: EXPERIMENTAL
Intervention: Vaccine A (Edmonston-Zagreb, Leningrad-Zagreb, RA 27/3 strains)
Number of subjects: 10142

Group type: EXPERIMENTAL
Intervention: Vaccine B (Moraten, Jeryl Lynn, Wistar 27/3 strains)
Number of subjects: 10142

Group type: EXPERIMENTAL
Intervention: Vaccine C (Schwartz, Urabe AM-9, Wistar 27/3 strains)
Number of subjects: 10142

Group type: COMPARATOR
Intervention: Control group (not vaccinated)
Number of subjects: 10142
Study: 10507269

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (0.25 mg, 0.50 mg, or 1.0 mg)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (0.50 mg and 1.0 mg)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 359
Study: 8951479

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided prostate biopsy
Number of subjects: 170
Study: 31918984

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (HIIE) with 10% evening basal insulin reduction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (HIIE) with 20% evening basal insulin reduction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (HIIE) with 30% evening basal insulin reduction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-exercise control day
Number of subjects: 12
Study: 31358401

Group type: EXPERIMENTAL
Intervention: Red-blue irradiation treatment
Number of subjects: 118

Group type: COMPARATOR
Intervention: White-light irradiation (Control)
Number of subjects: 118
Study: 27416005

Group type: EXPERIMENTAL
Intervention: Supervised slackline training (EG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 22
Study: 25333776

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily for 26 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23345636

Group type: EXPERIMENTAL
Intervention: Shoulder taping and conventional treatment
Number of subjects: 162

Group type: COMPARATOR
Intervention: Sham taping and conventional treatment
Number of subjects: 162
Study: 21886365

Group type: EXPERIMENTAL
Intervention: auto‐CPAP for 2 nights and continued for 30 days for those with sleep apnea
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: auto‐CPAP use
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no auto‐CPAP)
Number of subjects: 55
Study: 18715634

Group type: EXPERIMENTAL
Intervention: Modified IMCI guidelines implemented after September 2004
Number of subjects: 1532
Study: 15900287

Group type: EXPERIMENTAL
Intervention: Goldenseal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Kava Kava
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Black Cohosh
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Valerian
Number of subjects: 12
Study: 12859140

Group type: EXPERIMENTAL
Intervention: Dalbavancin; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 11113028

Group type: EXPERIMENTAL
Intervention: Antipyretic therapy (nonsteroidal anti-inflammatory drugs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antipyretic therapy
Number of subjects: 0
Study: 9139620

Group type: EXPERIMENTAL
Intervention: LDL apheresis
Number of subjects: 30
Study: 1642652

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Combination therapy (AZA + MTX)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 212
Study: 6430063

Group type: EXPERIMENTAL
Intervention: Lithium carbonate 300 mg t.i.d.
Number of subjects: 85

Group type: COMPARATOR
Intervention: No lithium (Control)
Number of subjects: 85
Study: 31731611

Group type: EXPERIMENTAL
Intervention: Supportive Parenting Intervention (six home visits by a trained Youth Health Care nurse during the first 18 months)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Care-as-usual (control group)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Supportive Parenting Intervention
Number of subjects: 301
Study: 30076573

Group type: EXPERIMENTAL
Intervention: Electronic notifications to primary care physicians
Number of subjects: 2336

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2336
Study: 27220523

Group type: EXPERIMENTAL
Intervention: Tablet PC questionnaire
Number of subjects: 178

Group type: COMPARATOR
Intervention: Paper questionnaire
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 178

Group type: COMPARATOR
Intervention: Both methods (tablet PC and paper)
Number of subjects: 178
Study: 22830517

Group type: EXPERIMENTAL
Intervention: LT peel (lidocaine 70 mg/g and tetracaine 70 mg/g)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 22313266

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (SunLase™ 800) - two-minute group
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (SunLase™ 800) - one-minute group
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Gluma® desensitizer
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tenure Quick®
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Quell™ desensitizer
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: VivaSens®
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (untreated dentin surface)
Number of subjects: 64
Study: 20586916

Group type: EXPERIMENTAL
Intervention: Endovascular therapies (thrombolytic therapy)
Number of subjects: 95
Study: 18247267

Group type: EXPERIMENTAL
Intervention: Job-related programme (intervention group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual rehabilitation interventions (control group)
Number of subjects: 300
Study: 16221898

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12608943

Group type: EXPERIMENTAL
Intervention: Alendronate treatment at a dose of 10 mg/day for 12 months
Number of subjects: 68
Study: 10509846

Group type: EXPERIMENTAL
Intervention: Sparfloxacin (400 mg on day 1, 200 mg daily on days 2‐4)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg BID)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Combination of sparfloxacin and terfenadine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 8605132

Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy
Number of subjects: 143

Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 143
Study: 1940190

Group type: EXPERIMENTAL
Intervention: Low-dose antacid (AA, Supralox, 1 tablet three times a day 1 h a.c. and 2 tablets at bedtime, with acid binding capacity of 225 mEq)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Misoprostol (MS, Cytotec, 400 micrograms p.o. b.i.d.)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose antacid (AA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Misoprostol (MS)
Number of subjects: 100
Study: 6757394

Group type: EXPERIMENTAL
Intervention: Work-site (WS) treatment program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regular care (RC)
Number of subjects: 100
Study: 29516455

Group type: EXPERIMENTAL
Intervention: Dolphin Assisted Therapy (DAT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Therapeutical Intervention Without Dolphins (TIWD)
Number of subjects: 44
Study: 27343343

Group type: EXPERIMENTAL
Intervention: Home-based upper limb training program for 8 weeks, twice a week
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group received information in the form of a leaflet with a schedule of upper limb exercise training
Number of subjects: 37
Study: 25350855

Group type: EXPERIMENTAL
Intervention: Checklist-based tool for management of postoperative complications
Number of subjects: 20

Group type: COMPARATOR
Intervention: No checklist
Number of subjects: 20
Study: 22307144

Group type: EXPERIMENTAL
Intervention: Health‐promotion intervention (7-session program, 2 hours per session)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Health‐promotion intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 20925565

Group type: EXPERIMENTAL
Intervention: Telehome monitoring device
Number of subjects: 0
Study: 18589766

Group type: EXPERIMENTAL
Intervention: Naoxinqing tablet
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Naoxinqing tablet + half dose Simvastatin
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Full dose Simvastatin
Number of subjects: 66
Study: 12760517

Group type: EXPERIMENTAL
Intervention: Familiarization with fluent speech containing words that fit phonological patterns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Familiarization with fluent speech containing words that violated phonological patterns
Number of subjects: 0